ENOV vs PJT
ENOV: A medical technology company providing a comprehensive continuum of orthopedic care, from injury prevention and rehabilitation products to surgical reconstructive implants. PJT: An independent, global investment bank providing high-touch, expert financial advisory services in strategic M&A, complex restructuring, and alternative asset fundraising.
Side-by-side fundamentals
| Metric | ENOV | PJT | Edge |
|---|---|---|---|
| Price as of 2026-07-23 close | $26.06 | $164.20 | |
| Market cap as of 2026-07-25 | $1.5B | $4.3B | |
| P/E as of 2026-07-25 | n/a | 23.29 | |
| PEG as of 2026-07-25 | -0.04 | n/a | |
| Net margin as of 2026-07-25 | -49.9% | +10.3% | PJT higher |
| Gross margin as of 2026-07-25 | +60.4% | n/a | |
| Operating margin as of 2026-07-25 | -47.1% | +21.6% | PJT higher |
| ROE as of 2026-07-25 | -60.1% | +76.4% | PJT higher |
| ROA as of 2026-07-25 | -26.6% | +11.3% | PJT higher |
| Debt / equity as of 2026-07-25 | 0.90 | 0.00 | PJT lower |
| Revenue growth (YoY) as of 2026-07-25 | +6.0% | +21.4% | PJT higher |
| Revenue CAGR (3y) SEC XBRL | +12.9% | +18.7% | PJT higher |
| Dividend yield as of 2026-07-25 | n/a | +0.6% | |
| Beta as of 2026-07-25 | 1.44 | 0.83 | |
| 1-year return as of 2026-07-23 close | -5.9% | -9.1% | ENOV higher |
Fundamentals: Finnhub, as of 2026-07-25. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-23.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.